Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Halo Labs Completes Issuance of Shares to Independent Consultants and Supplier
By Business Wire
Originally Published: Apr 28, 2020
Not for Distribution to U.S. Newswire Servicers or For Dissemination in the United States
TORONTO — Halo Labs Inc. (“Halo” or the “Company”) (NEO: HALO, OTCQX: AGEEF, Germany: A9KN) today announced the issuance of 10,860,213 common shares of the Company to certain independent consultants of the Company and a supplier of the Company, in lieu of cash consideration (the “Compensation Shares”) at a price of C$0.115 per Compensation Share, being the closing price of the common shares of the Company on April 3, 2020.
On April 27, 2020 the Company issued 10,860,213 Compensation Shares in satisfaction of approximately C$1,248,925 in fees, payables, and other compensation accrued between December 2019 and April 2020 and payable to independent consultants of the Company and a supplier of the Company. All of the Compensation Shares were issued pursuant to an exemption from the prospectus requirement of applicable securities laws. 1,567,330 of the Compensation Shares, representing all of the Compensation Shares issued to a supplier, are subject to a hold period of four months and one day from the date of issuance. No Compensation Shares were issued to related parties (within the meaning of Multilateral Instrument 61-101 – Protection of Minority Security Holders in Special Transactions (“MI 61-101”)).
About Halo Labs
Halo is a leading cannabis cultivation, manufacturing, and distribution company that grows, extracts, and processes quality cannabis flower, oils, and concentrates. Halo sold over 5 million grams of oils and concentrates since inception and has continued to evolve its business through delivering value with its products. Via verticalization, Halo has expanded in key markets in the United States and Africa with planned expansion into European and Canadian markets. With a consumer-centric focus, Halo markets innovative, branded, and private label products across multiple product categories.
Recently, Halo entered into binding agreements to acquire one dispensary in Los Angeles, three KushBar branded dispensaries, five development permits in Alberta Canada, and Canmart Limited which holds wholesale distribution and special licenses allowing the import and distribution of cannabis based products for medicinal use (CBPM’s) in the United Kingdom. Halo is led by a strong, diverse management team with deep industry knowledge and blue-chip experience. The Company is currently operating in the United States in California, Oregon, and Nevada, while having an international presence in Lesotho within a planned 200+ hectare cultivation zone via Bophelo as well as planned importation and distribution in the United Kingdom via Canmart.
For further information regarding Halo, see Halo’s disclosure documents on SEDAR at www.sedar.com.
Yes I suspect more selling, and I will wait for bargains also, but my impression is everything is just a matter of timing and could be announced at will. Online sales are soon also
They are on schedule for partnership and launch by end of June, of course it remains a fluid situation because of COVID 19. If changes a press release will update situation.
See if we can find out more, any guesses longs? To who it may be
definitive manufacturing agreement with US infant nutrition partner during Q2-2020;
https://www.google.com/amp/s/finance.yahoo.com/amphtml/news/else-nutrition-provides-corporate-113000725.html
Been in here a few weeks since .08’s, as some stated this is the most interesting float I’ve ever been part of. To that, I haven’t sold a share but not many know of this stock. Gotta spread the word
Patents and thoughts:
https://ibb.co/XLTB7CY
After reading in depth, I agree, that ELSE has solid patents for all their product lines: infant, toddlers and adult nutrition.
Patents cover all compositions that include (among others) an almond and a non-dairy components as in the claims regardless if those are the only ingredients or not.
Also, the plant based food market will be an $85 billion market opportunity. Enough room for several successful companies which will obviously happen. My money is on ELSE NUTRITION being one of them! GLTA
Just a matter of time. LABS had the foresight for international growth, Canadian market over saturated. Worldwide pharmaceutical cannabis company!!!
Web site below:
Savvy food companies beef up their IP protection for vegan products
There’s a veggie-driven revolution going on in the food industry right now. Led by customer demand for meat alternatives (the number of vegans in Britain has risen by 360% in 10 years), more and more businesses are seeking to develop plant-based options. In a bid to differentiate themselves from competitors, companies have turned to innovative product development which, in some cases, has created an Intellectual Property (IP) opportunity.
In this article, Trade Mark Attorney Jill Matchett and Trainee Patent Attorney Dr Will Dean take a look at a handful of companies which have been able to develop new and exciting products, often making use of the scientific research behind the product development to successfully patent the formulation or how the product is made. They also discuss how to identify whether or not a product has the potential to be patented and the benefit of taking steps to protect the IP – not just with regard to patents, but also trade marks.
One company trailblazing the meat-free approach is Silicon Valley start-up Impossible Foods, which has created a vegan burger that actually looks and tastes like a beef burger. It is one of many businesses – others include Beyond Meat and Clara Foods – that appeal to those looking to follow a vegan, vegetarian or flexitarian diet (where people eat mainly a plant-based diet but occasionally eat meat). These organisations are no longer simply targeting vegetarians, but are also tempting traditional meat-eaters to buy their products, in order to make the global food system more sustainable and environmentally friendly.
According to Impossible Food’s website, their plant-based burger ‘uses 95% less land, 74% less water, and creates 87% less greenhouse gas emissions than a traditional meat based burger’. The burger is made using genetically engineered yeast to create commercially useful levels of haem-containing proteins, similar to blood’s haemoglobin, which gives it a ‘meat-bleed’ character.
To protect the product, Impossible Foods has applied for a number of patents; recognising that their idea is commercially valuable and that the research behind it should be safeguarded from copycats. One of the patent applications is for a ‘ground meat replica’, which features a clever combination of previously-known ingredients that have a newly-recognised benefit when used together. This patent application describes taste tests performed by trained flavour scientists and laboratory tests to provide evidence that the products have a more meat-like texture, appearance and flavour as compared to traditional meat substitutes.
An older, but still important, example of an innovative meat substitute is the fungi-based Quorn food product. Rank Hovis McDougall, co-founders of the Quorn company Marlow Foods Limited, filed a family of patent applications in the early 1980s to protect the manufacturing process for making the Quorn meat substitute, as well as the product itself. Subsequent patent applications by Marlow Foods Limited have sought to protect further developments in relation to edible fungus products, building up a suite of IP rights. The exclusive rights gained from the granted patents helped Quorn to develop a strong market share and establish a now-famous brand. The eventual expiry of the original Quorn patents wasn’t a concern for CEO Kevin Brennan, when interviewed in 2011, as he was confident in the company’s strength of technical know-how. By that stage their brand was extremely well established.
This example highlights why, even where research and scientific innovation is at the heart of a company’s new product development and patent protection is possible, companies also need to ensure that names, logos and other identifiable elements are protected through trade marks. Savvy branding, early registration and protection of those brands in countries other than those where the product is first traded ensures that the brands are protected long term.
Together, patent and trade mark protection make for a powerful combination, so when patents expire (after 20 years), the brand is so strong that copycat manufacturers fail to make inroads into market share.
Another example of use of the IP system to obtain a strong foothold in the food and drink sector can be found in relation to dairy-substitute beverages, where there has been a consumer trend towards soy and nut-based milks. In this regard, WhiteWave (parent company of Alpro in Europe) has made its brands for plant-based consumables, establishing the names Provamel, Alpro and Silk. The company’s innovation in this area is protected through patents for processes to make dairy-free milks, and for formulations of the products. Protecting this innovation, together with obtaining trade mark protection for the brands, means that WhiteWave has gained market dominance in much the same way as Quorn did. The value of the brands and food technology in the WhiteWave stable was evidenced by Danone’s $12.5bn acquisition of WhiteWave, which completed in April 2017.
Is your product patentable?
The key factors to bear in mind when considering whether your idea is patentable are:
Is your idea new?
Does your idea solve a problem?
Is your idea commercially valuable?
If the answer to these questions is ‘yes’, it’s worth thinking about protecting your idea using patents.
Examples of potentially patentable developments in the food and drink sector include:
Individual ingredients, such as flavourings, texturising agents or antioxidants
Processes to produce or treat ingredients
Combinations of ingredients (contrary to popular belief, recipes can be patentable!)
Ways of combining ingredients
Techniques to make a known product taste better or have better mouth-feel
Methods for improving shelf life
Packaging modifications
In a lot of cases that we’ve seen, when time and effort have been put into developing and perfecting a new product or process, seeking patent protection was a viable option.
Regarding patent and Beyond Meat
https://www.lexology.com/library/detail.aspx?g=786d1187-49bb-4c98-a9a5-3286223839c0
So ELSE has products that have never existed and are protected from future copy cats;
To be patentable, an invention must also be "novel" and "nonobvious," as determined by 35 U.S.C. 102 and 35 U.S.C. 103, respectively. That means a patentable invention can neither have existed before, nor be an obvious improvement or alteration of a previously known invention, which could be determined by someone with reasonable skill in the art encompassed by the invention.
Else Investors Information:
Else raised CAD 8 Million in February of this year, the round was led by the H&H Group, a baby products conglomerate based (and traded) in Honk Kong that invested CAD 5.75 Millions, signed and MOU for distribution rights in several territories, joined our board and is holding 11.15% of our stock.
This puts Else in a very strong cash position – close to CAD 10 Millions, that gives us air for more than 15 months and for doing a strong US launch as early as possible during that time (they are still planning to launch this quarter/ 2020).
Their operational burn rate is low, most of their funds will go for production and marketing.
BREAKDOWN:
$10 million in the bank
No debt
33 million shares floating
Launch in June 2020 in USA
Sales in Israel $ 1 million per year
H&H is our partner, a $ 1.3 billion company, invested 64 cents, options 94 cents, clause that they are 1st investors in the future to keep percentage same.
H&H to launch product in China, Europe and Austrialia
Words of H&H, MASSIVE GROWTH for this product
Next year: gold product for infant formula - massive market
Willymon, I can volunteer you my ibox if you want it, you are by far one of the most qualified, u interested?
I will update this weekend my ibox, bring attention to all the catalysts
They have over 10 million cash, over 15 months leeway, in this crisis
There burn rate is very low. The company is made up of 12 people. Most their money will go to marketing and production.
Welcome happyglass!! Different sector my friend
From long investor: passing on
$10 million in the bank
No debt
33 million shares floating
Launch in June 2020 in USA
Sales in Isreal $ 1 million per year
H&H is our partner, a $ 13 billion company, invested 64 cents, options 94 cents, clause that they are 1st investors in the future to keep percentage same.
H&H to launch product in China, Erurope and Austrialia
Words of H&H, MASSIVE GROWTH for this product
Next year: gold product for infant formula - massive market
Hey guys , stop by and help fill up the new Facebook Cordia Corp investor group. Thanks, long on this one!!!
https://m.facebook.com/groups/224082975595136?tsid=0.7797952932264086&source=result
I think we got rid of some shorts today... see if the spread gets a little better.
Panic selling and its a speculative stock.... I bought more on the dip, I’m long and these crazy times will pass. GL
Hell of a range in sp today, been looking at this.. any investor presentation for $CORG? Nothing on website unless I overlooked it. Looks interesting here, not yet found which is nice.
Not sure those that are “comparing,
or cheerleading this stock are naive to any risk or loss here, this isn’t a cd, or a savings bank or a big blue chip dividend stock, we are betting on an otc stock. That being said, this stock has a growth possibility in a first mover advantage, international markets and a new and wanted product. I, myself invest in only a few otc stocks because of the risk to reward is in my favor of becoming wealthy, plain and simple! Yes, if your money isn’t in the bank and anywhere in the market you roll the dice ... GLTA, let’s look at possible risks:
He sums it up better than I could have;
The risks attached to an early stage food company are that the product tastes awful (I tasted it at a conference several months ago and it’s fine), that it will have a terrible texture (it doesn’t), that it will contain chemicals that folks will object to (it doesn’t – everything in the product is plant-based), and that someone else will imitate the product and wipe out your market (which is where those patents come in handy).
The biggest risk is whether or not the market wants your product.
To that end:
Else Nutrition concluded a comprehensive U.S. customer study, conducted by Wizer, a leading market research provider. The study assessed the perceptions, needs and behaviour of parents/caregivers regarding their children’s nutrition, and their response to Else Nutrition product concept. The Web-based survey of over 1,858 prospective customers (who are the primary decision makers regarding household grocery purchases) spanned 13 major U.S. metropolitan areas, including New York, Los Angeles, Chicago, Boston, Washington, D.C., Philadelphia, Miami, San Francisco, San Diego, Seattle, and Portland, Ore. All surveyed have a child between the ages of three months to three years of age.
The key findings showed that:
Over 82 per cent (top two boxes) of respondents reacted favourably to the Else brand concept.
Over 60 per cent (top two boxes) of respondents indicated positive purchase intent for Else’s baby formula products.
Additionally, 40% of respondents acknowledged they buy existing specialty (medical/prescribed milk formula, soy-based formula, or sensitive milk formula) baby nutrition products.
40%!
Imagine if 40% of bread consumers were allergic, sensitive, and intolerant of traditional bread, and you had the only patent on a bread product that fixes all of those issues at once. That’d probably be a hot ticket.
With so many people having been attracted to Beyond Meat (BYND.Q) and similar alternate food offerings in the last year, there’s a real shift afoot in the consumer packaged goods sector, right as Else is hitting its stride.
And I’m talking about it not because they’re a client, but because it’s necessary for what Else has created to exist in the world, so that hundreds of millions can take their kids off trashy formula products.
https://equity.guru/2020/01/29/else-nutrition-baby-c-riding-plant-based-foods-wave-three-bagger/
Your welcome !
I expect some news this week and an official earnings date released by LABS, slow uptick lately we will take it. Monday is also their participation in the KCSA Virtual Investor Conference on April 20th at 1:30pm ET. GLTA
For those who haven’t seen or read about MONSTER STOCK, here is an interesting read, what is relevant to $BABY is the potential of a 100 bagger! $BABY has a unique product and a brand that will be highly recognizable. Key is who will hold long enough for the pay out. GLTA
read in sequence:
1. https://ibb.co/FhHsp2V
2. https://ibb.co/qW5t4Js
3. https://ibb.co/YPZfKJL
4. https://ibb.co/RzTQvVY
5. https://ibb.co/SV7r2FQ
6. https://ibb.co/k2s4Z12
7. https://ibb.co/9YmZ3L9
Hard to say because LABS had been down 90 percent of the time since HEXO debacle!! wtf
Bring it!! Cheap still!!
Looking forward to next week! Long on this one!
Same thing every single time with VLNS & LABS , just saying! good or average sell off
You as well... I’m hanging on tightly
Keep selling, that’s all you do!! Block after block
I’m trying to stay positive, but is the CANNABIS SECTOR, including LABS, done!! Dead money??
Thank you, perfect!! Read that somewhere but couldn’t remember. Appreciate the help! Cheers
Hey Pisd,
https://ibb.co/VvXtVwb
Above is the final unlock that came on March 31st, no sells on Sedar and no CEO has sold any shares ever. But this seed shareholder bought for .84 cents and seems to need the money
I came up with this, so far:
https://ceo.ca/api/sedi/?symbol=baby&amount=&transaction=&insider=
Anyone know off hand the current insider holding? Or any buying by insiders, thnx been looking myself too
Like the scenario!!! Meanwhile the dweeb keeps dumping millions of warrants......